The Patent Finder
US

Injector

US D673,264 In force, term unresolved
OverviewFamilyAssignmentsSources & methods

Term ends no later than Dec 25, 2026 · Medium confidence

In force on USPTO's status record. A terminal disclaimer on file may shorten this term, possibly to a date already past; its reference document is unresolved, so the date above is an upper bound and no earlier date is guessed.

Held by Novartis AG
Filed Jan 19, 2010 as application 29/354,032 · Granted Dec 25, 2012
Base term, 14 years from grant
Today
14 years from grant
2012 2026
Clock starts
Dec 25, 2012
Ends no later than
Dec 25, 2026
base term Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
Unresolved
Terminal disclaimer
On file, reference document not resolved, so the date above is an upper bound. We do not guess the cap.
14 years from grant
Base term
No maintenance fees are payable on this kind of patent.
22
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term is its base term, 14 years from grant, with no adjustment for prosecution delay. A terminal disclaimer is on file with no resolved reference, so no cap is applied and none is guessed. No maintenance fees are payable on this kind of patent. Confidence: Medium. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 14 years from grantGranted Dec 25, 2012Dec 25, 2026High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capDisclaimer on file (approved), reference document not resolvedno cap applied, and none guessedMedium confidence
Patent term extensionNone on fileno changeHigh confidence
Computed term endThe steps above, in orderno later than Dec 25, 2026Medium confidence

This family

US 9,011,386In force
Oct 2032
Oct 2032
US D673,264this patent
no later than Dec 2026
no later than Dec 2026
US 9,033,935In force
Jul 2031
Jul 2031
US 9,033,936In force
May 2031
May 2031
US 9,005,160In force
Dec 2031
Dec 2031
US 8,986,245In force
Jul 2031
Jul 2031
US 9,033,932In force
Jul 2032
Jul 2032
US 9,011,375In force
Feb 2032
Feb 2032
8 of 22 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Jan 19, 2010
Reel 23826, frame 403
Kunze, KatjaSHL Group ABAssignment of Assignor's Interest
Aug 1, 2016
Reel 39504, frame 486
Novartis Pharma AGNovartis AGAssignment of Assignor's Interest
Aug 1, 2016
Reel 39515, frame 740
SHL Group ABNovartis Pharma AGAssignment of Assignor's Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center

No maintenance fees are payable on this kind of patent, so the record carries no fee events.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited